Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Streoff
- Development stage
- Unknown
- Lead developer
- Arbro Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Streoff is an Ayurvedic proprietary formulation developed and marketed by Arbro Pharmaceuticals. It is a fixed-dose combination of Curcuma longa (turmeric) extract (curcumin) and Ashwagandha (Withania somnifera) oil. The product is designed to support stress relief, anxiety management, mood balance, immune function, and overall vitality. The curcumin in Streoff is formulated in a Self Nano Emulsifying form to enhance its bioavailability and absorption.
- Brand names
- Streoff
- Other names
- Curcumin + Ashwagandha OilStreoff Capsules
Beyond the preview
Go deeper on Streoff.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Streoff.